BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15957606)

  • 1. Auto-immune-like cone dystrophy.
    Hargitai J; MacKay C; Behrens M; Odel JG; Hood DC; Gouras P
    Doc Ophthalmol; 2004 Nov; 109(3):215-21. PubMed ID: 15957606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kiloDalton.
    Parc CE; Azan E; Bonnel S; Sahel JA; Kaplan J; Thirkill CE
    Ophthalmic Genet; 2006 Jun; 27(2):57-61. PubMed ID: 16754207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral cone dystrophy: a variant of cone dystrophy with predominant dysfunction in the peripheral cone system.
    Kondo M; Miyake Y; Kondo N; Ueno S; Takakuwa H; Terasaki H
    Ophthalmology; 2004 Apr; 111(4):732-9. PubMed ID: 15051206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive cone dystrophy with deutan genotype and phenotype.
    Scholl HP; Kremers J; Besch D; Zrenner E; Jägle H
    Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):183-91. PubMed ID: 16082559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune retinopathy in the absence of cancer.
    Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
    Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rod and cone photoreceptor function in patients with cone dystrophy.
    Holopigian K; Greenstein VC; Seiple W; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):275-81. PubMed ID: 14691184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rod and cone a-waves in three cases of Bietti crystalline chorioretinal dystrophy.
    Usui T; Tanimoto N; Takagi M; Hasegawa S; Abe H
    Am J Ophthalmol; 2001 Sep; 132(3):395-402. PubMed ID: 11530054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human retinal disease from AIPL1 gene mutations: foveal cone loss with minimal macular photoreceptors and rod function remaining.
    Jacobson SG; Cideciyan AV; Aleman TS; Sumaroka A; Roman AJ; Swider M; Schwartz SB; Banin E; Stone EM
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):70-9. PubMed ID: 20702822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology.
    Mantel I; Ramchand KV; Holder GE; Ohbayashi M; Morohoshi K; Patel N; Toda M; Fitzke FW; Bird AC; Ono SJ
    Exp Mol Pathol; 2008 Apr; 84(2):90-101. PubMed ID: 18255057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human S-cone electroretinograms obtained by silent substitution stimulation.
    Maguire J; Parry NRA; Kremers J; Murray IJ; McKeefry D
    J Opt Soc Am A Opt Image Sci Vis; 2018 Apr; 35(4):B11-B18. PubMed ID: 29603933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cone dysfunction in patients with late-onset cone dystrophy and age-related macular degeneration.
    Ladewig M; Kraus H; Foerster MH; Kellner U
    Arch Ophthalmol; 2003 Nov; 121(11):1557-61. PubMed ID: 14609911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
    Adamus G; Ren G; Weleber RG
    BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local cone and rod system function in progressive cone dystrophy.
    Holopigian K; Seiple W; Greenstein VC; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2364-73. PubMed ID: 12091439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective cone dystrophy with protan genotype.
    Kellner U; Sadowski B; Zrenner E; Foerster MH
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2381-7. PubMed ID: 7591627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective reduction of S-cone response and on-response in the cone electroretinograms of patients with X-linked retinoschisis.
    Yamamoto S; Hayashi M; Tsuruoka M; Ogata K; Tsukahara I; Yamamoto T; Takeuchi S
    Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):457-60. PubMed ID: 12107512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroretinography and optical coherence tomography reveal abnormal post-photoreceptoral activity and altered retinal lamination in patients with enhanced S-cone syndrome.
    Sustar M; Perovšek D; Cima I; Stirn-Kranjc B; Hawlina M; Brecelj J
    Doc Ophthalmol; 2015 Jun; 130(3):165-77. PubMed ID: 25663266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies.
    Forooghian F; Sproule M; Westall C; Gordon L; Jirawuthiworavong G; Shimazaki K; O'Connor P
    Doc Ophthalmol; 2006 Sep; 113(2):123-32. PubMed ID: 16972082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive cone dystrophy associated with mutation in CNGB3.
    Michaelides M; Aligianis IA; Ainsworth JR; Good P; Mollon JD; Maher ER; Moore AT; Hunt DM
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1975-82. PubMed ID: 15161866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases.
    Nishiguchi KM; Sandberg MA; Gorji N; Berson EL; Dryja TP
    Hum Mutat; 2005 Mar; 25(3):248-58. PubMed ID: 15712225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.